Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.1 PLN | +0.90% | +10.18% | -25.44% |
29/05 | Bioceltix S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/04 | Bioceltix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 42 | 13/18/13 | |
Andrij Wlach
DFI | Director of Finance/CFO | 40 | - |
Elzbieta Gocek
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jakub Grzesiak
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Pawel Wielgus
PRN | Corporate Officer/Principal | 43 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,129,468 | 2,785,920 ( 67.46 %) | 0 | 67.46 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-25.44% | 67.7M | |
-13.59% | 77.82B | |
+21.01% | 8.91B | |
-5.56% | 3.04B | |
+13.68% | 1.67B | |
-5.27% | 1.23B | |
-29.81% | 1.16B | |
-31.11% | 1.15B | |
-22.47% | 1.01B | |
-12.32% | 916M |
- Stock Market
- Equities
- BCX Stock
- Company Bioceltix S.A.